STAAR Surgical director receives stock and option awards

STAAR Surgical director Arthur C. Butcher exercised 5,341 restricted stock units into Common Stock on June 18, 2026, bringing his direct Common Stock holdings to 9,549 shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

STAAR Surgical director Arthur C. Butcher exercised 5,341 restricted stock units into Common Stock on June 18, 2026, bringing his direct Common Stock holdings to 9,549 shares.

He also received 3,709 new restricted stock units and 4,458 stock options at a $29.12 exercise price, which vest in full on the earlier of June 18, 2027 or the 2027 Annual Meeting of Shareholders.

Insider Trade Summary

5,341 shares exercised/converted

Exercise 4 txns

Insider Butcher Arthur C

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	5,341	$0.00	$0.00
Grant/Award	Common Stock Options	4,458	$0.00	$0.00
Grant/Award	Restricted Stock Units	3,709	$0.00	$0.00
Exercise	Common Stock	5,341	$0.00	$0.00

Holdings After Transaction: Common Stock Options — 4,458 contracts (Direct); Restricted Stock Units — 3,709 contracts (Direct); Common Stock — 9,549 shares (Direct)

Footnotes (2)

F1. Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.
F2. Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Key Figures

RSUs exercised: 5,341 shares Common shares held: 9,549 shares New RSU grant: 3,709 units +3 more

6 metrics

RSUs exercised 5,341 shares Restricted stock units converted to Common Stock on June 18, 2026

Common shares held 9,549 shares Direct Common Stock ownership after transactions

New RSU grant 3,709 units Restricted Stock Units granted June 18, 2026 for 2026–2027 term

Option grant size 4,458 options Options to purchase Common Stock granted June 18, 2026

Option exercise price $29.12 per share Strike price for 4,458 stock options

Option expiration June 17, 2036 Expiration date of newly granted stock options

Key Terms

Restricted Stock Units, non-employee director equity compensation program, options to purchase common stock, Annual Meeting of Shareholders

4 terms

Restricted Stock Units financial

"Reflects restricted stock units granted to the Reporting Person on June 18, 2025..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-employee director equity compensation program financial

"pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term..."

options to purchase common stock financial

"Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026..."

Annual Meeting of Shareholders financial

"These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did STAAR Surgical (STAA) director Arthur Butcher report?

Arthur C. Butcher exercised 5,341 restricted stock units into Common Stock and received 3,709 new restricted stock units plus 4,458 stock options. All actions occurred on June 18, 2026 under the company’s non-employee director equity compensation programs.

How many STAAR Surgical (STAA) shares does Arthur Butcher hold after these transactions?

After exercising 5,341 restricted stock units, Arthur C. Butcher directly holds 9,549 shares of STAAR Surgical Common Stock. These holdings reflect only the position reported in this Form 4 and exclude unvested restricted stock units and options reported separately.

What are the terms of Arthur Butcher’s new STAAR Surgical stock options?

Arthur C. Butcher received 4,458 options to purchase STAAR Surgical Common Stock at an exercise price of $29.12 per share. These options vest in full on the earlier of June 18, 2027 or the company’s 2027 Annual Meeting of Shareholders and expire June 17, 2036.

What restricted stock units did Arthur Butcher receive from STAAR Surgical (STAA)?

He was granted 3,709 restricted stock units on June 18, 2026 under the 2026–2027 non-employee director equity compensation program. These units vest in full on the earlier of June 18, 2027 or STAAR Surgical’s 2027 Annual Meeting of Shareholders, then convert into Common Stock.

What prior STAAR Surgical equity awards vested for Arthur Butcher on June 18, 2026?

Restricted stock units granted on June 18, 2025 for STAAR Surgical’s 2025–2026 non-employee director equity program vested on June 18, 2026. The vesting of these 5,341 units led to the corresponding acquisition of 5,341 shares of Common Stock reported in this filing.

Were any STAAR Surgical (STAA) shares sold in Arthur Butcher’s Form 4?

No sales were reported. The Form 4 shows only acquisitions: an RSU vesting into 5,341 Common shares, a grant of 3,709 new restricted stock units, and a grant of 4,458 stock options. There are no dispositions or tax-withholding sales in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/22/2026 - 04:05 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Butcher Arthur C

(Last)

(First)

(Middle)

25510 COMMERCENTRE DRIVE

(Street)

LAKE FOREST

CALIFORNIA

92630

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	06/18/2026		M		5,341	A	$0	9,549	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units⁽¹⁾	$0	06/18/2026		M			5,341	⁽¹⁾	⁽¹⁾	Common Stock	5,341	$0	0	D
Common Stock Options⁽²⁾	$29.12	06/18/2026		A		4,458		06/18/2027	06/17/2036	Common Stock	4,458	$0	4,458	D
Restricted Stock Units⁽²⁾	$0	06/18/2026		A		3,709		⁽²⁾	⁽²⁾	Common Stock	3,709	$0	3,709	D

Explanation of Responses:

1. Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

2. Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Remarks:

This Form 4 reflects the equity awards granted to the Reporting Person on June 18, 2026 pursuant to Issuer's annual non-employee director equity compensation program for the 2026-2027 term.

	/s/ Kathleen Determann as attorney-in-fact for Arthur Butcher	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR